nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—NOS3—systemic scleroderma	0.746	1	CbGaD
Tetrahydrobiopterin—TH—cervicothoracic ganglion—systemic scleroderma	0.0495	0.433	CbGeAlD
Tetrahydrobiopterin—NOS3—pulmonary artery—systemic scleroderma	0.0123	0.107	CbGeAlD
Tetrahydrobiopterin—NOS3—umbilical vein—systemic scleroderma	0.0081	0.0707	CbGeAlD
Tetrahydrobiopterin—TH—artery—systemic scleroderma	0.00505	0.0441	CbGeAlD
Tetrahydrobiopterin—NOS3—artery—systemic scleroderma	0.00454	0.0397	CbGeAlD
Tetrahydrobiopterin—TH—blood vessel—systemic scleroderma	0.00393	0.0344	CbGeAlD
Tetrahydrobiopterin—NOS3—endothelium—systemic scleroderma	0.00384	0.0335	CbGeAlD
Tetrahydrobiopterin—NOS3—blood vessel—systemic scleroderma	0.00354	0.0309	CbGeAlD
Tetrahydrobiopterin—PTGS2—skeletal joint—systemic scleroderma	0.00344	0.0301	CbGeAlD
Tetrahydrobiopterin—TPH1—digestive system—systemic scleroderma	0.00306	0.0267	CbGeAlD
Tetrahydrobiopterin—TH—connective tissue—systemic scleroderma	0.00202	0.0176	CbGeAlD
Tetrahydrobiopterin—TH—Alpha-synuclein signaling—BLK—systemic scleroderma	0.0019	0.0603	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—connective tissue—systemic scleroderma	0.00181	0.0159	CbGeAlD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—ACE—systemic scleroderma	0.0018	0.057	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00166	0.624	CbGdCrCtD
Tetrahydrobiopterin—NOS3—smooth muscle tissue—systemic scleroderma	0.00166	0.0145	CbGeAlD
Tetrahydrobiopterin—TH—digestive system—systemic scleroderma	0.00146	0.0127	CbGeAlD
Tetrahydrobiopterin—PTGS2—artery—systemic scleroderma	0.00144	0.0126	CbGeAlD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.00136	0.0432	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TOP1—systemic scleroderma	0.00136	0.043	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—digestive system—systemic scleroderma	0.00131	0.0115	CbGeAlD
Tetrahydrobiopterin—NOS3—tendon—systemic scleroderma	0.00125	0.0109	CbGeAlD
Tetrahydrobiopterin—PTGS2—endothelium—systemic scleroderma	0.00122	0.0106	CbGeAlD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—COL1A2—systemic scleroderma	0.00118	0.0374	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—blood vessel—systemic scleroderma	0.00112	0.0098	CbGeAlD
Tetrahydrobiopterin—NOS3—lung—systemic scleroderma	0.00109	0.00956	CbGeAlD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.001	0.376	CbGdCrCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000924	0.0293	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—BLK—systemic scleroderma	0.00082	0.026	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Endothelin Pathways—EDN1—systemic scleroderma	0.000806	0.0256	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TOP1—systemic scleroderma	0.000779	0.0247	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000675	0.0214	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—EDN1—systemic scleroderma	0.000638	0.0202	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.000619	0.0196	CbGpPWpGaD
Tetrahydrobiopterin—TH—Monoamine Transport—IL1B—systemic scleroderma	0.000618	0.0196	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000581	0.0185	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—connective tissue—systemic scleroderma	0.000575	0.00502	CbGeAlD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—AIF1—systemic scleroderma	0.000574	0.0182	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—TGFB1—systemic scleroderma	0.000552	0.0175	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—MMP1—systemic scleroderma	0.000536	0.017	CbGpPWpGaD
Tetrahydrobiopterin—Upper respiratory tract infection—Leflunomide—systemic scleroderma	0.000535	0.0051	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000531	0.0168	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—smooth muscle tissue—systemic scleroderma	0.000526	0.0046	CbGeAlD
Tetrahydrobiopterin—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000524	0.005	CcSEcCtD
Tetrahydrobiopterin—Infection—Pentoxifylline—systemic scleroderma	0.000521	0.00497	CcSEcCtD
Tetrahydrobiopterin—PTGS2—skin of body—systemic scleroderma	0.000519	0.00454	CbGeAlD
Tetrahydrobiopterin—Neutropenia—Mycophenolic acid—systemic scleroderma	0.000513	0.0049	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Leflunomide—systemic scleroderma	0.000513	0.0049	CcSEcCtD
Tetrahydrobiopterin—Infestation—Leflunomide—systemic scleroderma	0.000513	0.0049	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Lisinopril—systemic scleroderma	0.000512	0.00488	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.00051	0.00487	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Pentoxifylline—systemic scleroderma	0.000509	0.00486	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiogenesis—MMP9—systemic scleroderma	0.000509	0.0161	CbGpPWpGaD
Tetrahydrobiopterin—Gastritis—Lisinopril—systemic scleroderma	0.000506	0.00483	CcSEcCtD
Tetrahydrobiopterin—TH—Dopaminergic Neurogenesis—TGFB1—systemic scleroderma	0.000506	0.0161	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.000503	0.016	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00478	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Leflunomide—systemic scleroderma	0.000499	0.00476	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.000495	0.0157	CbGpPWpGaD
Tetrahydrobiopterin—Infestation NOS—Mycophenolic acid—systemic scleroderma	0.000489	0.00467	CcSEcCtD
Tetrahydrobiopterin—Infestation—Mycophenolic acid—systemic scleroderma	0.000489	0.00467	CcSEcCtD
Tetrahydrobiopterin—Cough—Mometasone—systemic scleroderma	0.000483	0.00461	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.000479	0.0152	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.000477	0.00455	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Mycophenolic acid—systemic scleroderma	0.000476	0.00454	CcSEcCtD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.000475	0.0151	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Mometasone—systemic scleroderma	0.000472	0.0045	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Lisinopril—systemic scleroderma	0.000462	0.00441	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Pentoxifylline—systemic scleroderma	0.000461	0.0044	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.00046	0.00438	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Leflunomide—systemic scleroderma	0.000457	0.00436	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Leflunomide—systemic scleroderma	0.000454	0.00433	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Mometasone—systemic scleroderma	0.000452	0.00431	CcSEcCtD
Tetrahydrobiopterin—Infection—Mometasone—systemic scleroderma	0.000449	0.00429	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Mycophenolate mofetil—systemic scleroderma	0.000444	0.00423	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP2—systemic scleroderma	0.000441	0.014	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00044	0.00419	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.000436	0.00416	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CCL2—systemic scleroderma	0.000436	0.0138	CbGpPWpGaD
Tetrahydrobiopterin—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.000435	0.00415	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000433	0.00413	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Lisinopril—systemic scleroderma	0.000432	0.00412	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Lisinopril—systemic scleroderma	0.000429	0.00409	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000428	0.00409	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000425	0.0135	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Captopril—systemic scleroderma	0.000425	0.00405	CcSEcCtD
Tetrahydrobiopterin—PTGS2—digestive system—systemic scleroderma	0.000415	0.00363	CbGeAlD
Tetrahydrobiopterin—Mediastinal disorder—Leflunomide—systemic scleroderma	0.000415	0.00396	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Captopril—systemic scleroderma	0.000414	0.00395	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000414	0.00395	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000414	0.00395	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000412	0.00393	CcSEcCtD
Tetrahydrobiopterin—Hyperkinesia—Prednisone—systemic scleroderma	0.000408	0.0039	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000405	0.00387	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—CSK—systemic scleroderma	0.000403	0.0128	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Leflunomide—systemic scleroderma	0.000401	0.00383	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Methotrexate—systemic scleroderma	0.000398	0.0038	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Mometasone—systemic scleroderma	0.000398	0.0038	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Captopril—systemic scleroderma	0.000397	0.00379	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.000396	0.00378	CcSEcCtD
Tetrahydrobiopterin—PTGS2—tendon—systemic scleroderma	0.000395	0.00345	CbGeAlD
Tetrahydrobiopterin—Pharyngitis—Lisinopril—systemic scleroderma	0.000393	0.00375	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Lisinopril—systemic scleroderma	0.00039	0.00372	CcSEcCtD
Tetrahydrobiopterin—Infestation—Mycophenolate mofetil—systemic scleroderma	0.000386	0.00369	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	0.000386	0.00369	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000386	0.00368	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Mycophenolic acid—systemic scleroderma	0.000383	0.00365	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.000381	0.00363	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000379	0.00361	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.000376	0.0119	CbGpPWpGaD
Tetrahydrobiopterin—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00358	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00037	0.00353	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000362	0.00345	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic scleroderma	0.000362	0.0115	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Azathioprine—systemic scleroderma	0.000361	0.00345	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.00036	0.0114	CbGpPWpGaD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000359	0.00343	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000358	0.00342	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Mometasone—systemic scleroderma	0.000357	0.00341	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Mometasone—systemic scleroderma	0.000357	0.00341	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000357	0.0034	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000356	0.0113	CbGpPWpGaD
Tetrahydrobiopterin—Urine output increased—Methotrexate—systemic scleroderma	0.000354	0.00337	CcSEcCtD
Tetrahydrobiopterin—Agitation—Mycophenolic acid—systemic scleroderma	0.000352	0.00335	CcSEcCtD
Tetrahydrobiopterin—Cough—Leflunomide—systemic scleroderma	0.00035	0.00334	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Captopril—systemic scleroderma	0.00035	0.00333	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lung—systemic scleroderma	0.000347	0.00303	CbGeAlD
Tetrahydrobiopterin—Dizziness—Pentoxifylline—systemic scleroderma	0.000346	0.00331	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Lisinopril—systemic scleroderma	0.000345	0.00329	CcSEcCtD
Tetrahydrobiopterin—Infection—Azathioprine—systemic scleroderma	0.000344	0.00328	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00328	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00326	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Leflunomide—systemic scleroderma	0.000341	0.00326	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00034	0.00324	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000339	0.00323	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Azathioprine—systemic scleroderma	0.000337	0.00321	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000334	0.0106	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Mycophenolic acid—systemic scleroderma	0.000334	0.00318	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Pentoxifylline—systemic scleroderma	0.000333	0.00318	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Mycophenolic acid—systemic scleroderma	0.000331	0.00316	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP9—systemic scleroderma	0.000331	0.0105	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Pentoxifylline—systemic scleroderma	0.00033	0.00315	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00033	0.00315	CcSEcCtD
Tetrahydrobiopterin—Headache—Pentoxifylline—systemic scleroderma	0.000328	0.00313	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000327	0.00312	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000326	0.00311	CcSEcCtD
Tetrahydrobiopterin—Infection—Leflunomide—systemic scleroderma	0.000325	0.0031	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000325	0.0031	CcSEcCtD
Tetrahydrobiopterin—Irritability—Prednisone—systemic scleroderma	0.000324	0.00309	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000323	0.00309	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Methotrexate—systemic scleroderma	0.000323	0.00309	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Leflunomide—systemic scleroderma	0.000321	0.00306	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Leflunomide—systemic scleroderma	0.000318	0.00303	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000316	0.00301	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Captopril—systemic scleroderma	0.000314	0.00299	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Captopril—systemic scleroderma	0.000314	0.00299	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00298	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—MMP9—systemic scleroderma	0.000312	0.00989	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Pentoxifylline—systemic scleroderma	0.000311	0.00297	CcSEcCtD
Tetrahydrobiopterin—Infection—Mycophenolic acid—systemic scleroderma	0.00031	0.00296	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Mometasone—systemic scleroderma	0.000309	0.00295	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000306	0.00292	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000303	0.00289	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000303	0.00962	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000302	0.00288	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000301	0.00956	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.000301	0.00954	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Lisinopril—systemic scleroderma	0.000301	0.00287	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000299	0.00285	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000298	0.00284	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Lisinopril—systemic scleroderma	0.000293	0.0028	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000291	0.00278	CcSEcCtD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.000288	0.00916	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Leflunomide—systemic scleroderma	0.000288	0.00275	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Mometasone—systemic scleroderma	0.000287	0.00274	CcSEcCtD
Tetrahydrobiopterin—Rash—Mometasone—systemic scleroderma	0.000285	0.00272	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mometasone—systemic scleroderma	0.000285	0.00272	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000284	0.00271	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000283	0.0027	CcSEcCtD
Tetrahydrobiopterin—Headache—Mometasone—systemic scleroderma	0.000283	0.0027	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000283	0.0027	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000281	0.00268	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.00028	0.00889	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Lisinopril—systemic scleroderma	0.000279	0.00267	CcSEcCtD
Tetrahydrobiopterin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00265	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000275	0.00262	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Prednisone—systemic scleroderma	0.000275	0.00262	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Azathioprine—systemic scleroderma	0.000274	0.00261	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Azathioprine—systemic scleroderma	0.000274	0.00261	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Lisinopril—systemic scleroderma	0.000273	0.00261	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Captopril—systemic scleroderma	0.000272	0.00259	CcSEcCtD
Tetrahydrobiopterin—Irritability—Methotrexate—systemic scleroderma	0.000271	0.00259	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00027	0.00257	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mometasone—systemic scleroderma	0.000269	0.00256	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000268	0.00255	CcSEcCtD
Tetrahydrobiopterin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00251	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Captopril—systemic scleroderma	0.000263	0.00251	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000262	0.0025	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Leflunomide—systemic scleroderma	0.000259	0.00247	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Leflunomide—systemic scleroderma	0.000259	0.00247	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000258	0.00246	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.00245	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TGFB1—systemic scleroderma	0.000257	0.00815	CbGpPWpGaD
Tetrahydrobiopterin—Myocardial infarction—Prednisone—systemic scleroderma	0.000257	0.00245	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000256	0.00244	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000255	0.00244	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000255	0.00244	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00244	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Captopril—systemic scleroderma	0.000252	0.00241	CcSEcCtD
Tetrahydrobiopterin—Rash—Captopril—systemic scleroderma	0.00025	0.00239	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Captopril—systemic scleroderma	0.00025	0.00239	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—SELP—systemic scleroderma	0.00025	0.00793	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Captopril—systemic scleroderma	0.000249	0.00237	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Lisinopril—systemic scleroderma	0.000248	0.00236	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000247	0.00235	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000247	0.00235	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00235	CcSEcCtD
Tetrahydrobiopterin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00234	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000243	0.00232	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000242	0.00231	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000241	0.0023	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00228	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Azathioprine—systemic scleroderma	0.000237	0.00226	CcSEcCtD
Tetrahydrobiopterin—Nausea—Captopril—systemic scleroderma	0.000236	0.00225	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000234	0.00742	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—RHOB—systemic scleroderma	0.000233	0.0074	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.00023	0.0073	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00023	0.00219	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Methotrexate—systemic scleroderma	0.00023	0.00219	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Azathioprine—systemic scleroderma	0.000229	0.00219	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000228	0.00218	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000226	0.00719	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000224	0.00214	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Leflunomide—systemic scleroderma	0.000224	0.00214	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Lisinopril—systemic scleroderma	0.000222	0.00212	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Lisinopril—systemic scleroderma	0.000222	0.00212	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000222	0.00704	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Azathioprine—systemic scleroderma	0.00022	0.0021	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—systemic scleroderma	0.000219	0.00209	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—systemic scleroderma	0.000219	0.00209	CcSEcCtD
Tetrahydrobiopterin—Rash—Azathioprine—systemic scleroderma	0.000218	0.00208	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Azathioprine—systemic scleroderma	0.000218	0.00208	CcSEcCtD
Tetrahydrobiopterin—Headache—Azathioprine—systemic scleroderma	0.000217	0.00207	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00207	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—IL1B—systemic scleroderma	0.000217	0.00688	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Leflunomide—systemic scleroderma	0.000216	0.00206	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000214	0.00204	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000213	0.00203	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Leflunomide—systemic scleroderma	0.000208	0.00199	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000207	0.00198	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000206	0.00197	CcSEcCtD
Tetrahydrobiopterin—Rash—Leflunomide—systemic scleroderma	0.000206	0.00197	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Leflunomide—systemic scleroderma	0.000206	0.00197	CcSEcCtD
Tetrahydrobiopterin—Nausea—Azathioprine—systemic scleroderma	0.000206	0.00196	CcSEcCtD
Tetrahydrobiopterin—Headache—Leflunomide—systemic scleroderma	0.000205	0.00196	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Prednisone—systemic scleroderma	0.000205	0.00195	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—SMAD7—systemic scleroderma	0.000204	0.00649	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000201	0.00192	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000198	0.00189	CcSEcCtD
Tetrahydrobiopterin—Rash—Mycophenolic acid—systemic scleroderma	0.000197	0.00188	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000197	0.00188	CcSEcCtD
Tetrahydrobiopterin—Headache—Mycophenolic acid—systemic scleroderma	0.000196	0.00187	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—systemic scleroderma	0.000195	0.00186	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000195	0.00186	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000195	0.00186	CcSEcCtD
Tetrahydrobiopterin—Nausea—Leflunomide—systemic scleroderma	0.000194	0.00185	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Lisinopril—systemic scleroderma	0.000192	0.00184	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—SELP—systemic scleroderma	0.00019	0.00605	CbGpPWpGaD
Tetrahydrobiopterin—Agitation—Prednisone—systemic scleroderma	0.000188	0.00179	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—TGFBI—systemic scleroderma	0.000187	0.00594	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Lisinopril—systemic scleroderma	0.000186	0.00177	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mycophenolic acid—systemic scleroderma	0.000185	0.00177	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000182	0.00173	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Lisinopril—systemic scleroderma	0.000179	0.00171	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—RHOB—systemic scleroderma	0.000178	0.00565	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Lisinopril—systemic scleroderma	0.000177	0.00169	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Prednisone—systemic scleroderma	0.000177	0.00169	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Lisinopril—systemic scleroderma	0.000177	0.00169	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000177	0.00169	CcSEcCtD
Tetrahydrobiopterin—Headache—Lisinopril—systemic scleroderma	0.000176	0.00168	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Prednisone—systemic scleroderma	0.000174	0.00166	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000174	0.00553	CbGpPWpGaD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000173	0.00165	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methotrexate—systemic scleroderma	0.000171	0.00163	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—HSPG2—systemic scleroderma	0.000171	0.00542	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000169	0.00161	CcSEcCtD
Tetrahydrobiopterin—Nausea—Lisinopril—systemic scleroderma	0.000167	0.00159	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000167	0.00159	CcSEcCtD
Tetrahydrobiopterin—Infection—Prednisone—systemic scleroderma	0.000166	0.00158	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Prednisone—systemic scleroderma	0.000164	0.00156	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00155	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Prednisone—systemic scleroderma	0.000162	0.00155	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—CSK—systemic scleroderma	0.000162	0.00514	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00149	CcSEcCtD
Tetrahydrobiopterin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000155	0.00148	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000155	0.00148	CcSEcCtD
Tetrahydrobiopterin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00147	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—ITGAM—systemic scleroderma	0.000152	0.00483	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000152	0.00145	CcSEcCtD
Tetrahydrobiopterin—Cough—Methotrexate—systemic scleroderma	0.000149	0.00142	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—HSPG2—systemic scleroderma	0.000149	0.00473	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Methotrexate—systemic scleroderma	0.000148	0.00141	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Prednisone—systemic scleroderma	0.000147	0.0014	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000146	0.0014	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—systemic scleroderma	0.000146	0.00139	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000145	0.00138	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—CSK—systemic scleroderma	0.000144	0.00457	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	0.000143	0.00454	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00014	0.00133	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—systemic scleroderma	0.000139	0.00132	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000137	0.00131	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000137	0.0013	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—systemic scleroderma	0.000136	0.00129	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—CD247—systemic scleroderma	0.000135	0.0043	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Prednisone—systemic scleroderma	0.000132	0.00126	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Prednisone—systemic scleroderma	0.000132	0.00126	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—CTGF—systemic scleroderma	0.000129	0.00411	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000127	0.00121	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—HSPG2—systemic scleroderma	0.000125	0.00396	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Prednisone—systemic scleroderma	0.000123	0.00117	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—systemic scleroderma	0.000123	0.00117	CcSEcCtD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000121	0.00385	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00012	0.00115	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL1A—systemic scleroderma	0.000118	0.00376	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Prednisone—systemic scleroderma	0.000114	0.00109	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000114	0.00109	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—SMAD7—systemic scleroderma	0.000111	0.00353	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Prednisone—systemic scleroderma	0.00011	0.00105	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—systemic scleroderma	0.00011	0.00105	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—systemic scleroderma	0.00011	0.00105	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Prednisone—systemic scleroderma	0.000106	0.00101	CcSEcCtD
Tetrahydrobiopterin—Rash—Prednisone—systemic scleroderma	0.000105	0.001	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Prednisone—systemic scleroderma	0.000105	0.001	CcSEcCtD
Tetrahydrobiopterin—Headache—Prednisone—systemic scleroderma	0.000105	0.000998	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000103	0.00327	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000103	0.000981	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—TGFBI—systemic scleroderma	0.000102	0.00323	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Prednisone—systemic scleroderma	9.92e-05	0.000946	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—HSPG2—systemic scleroderma	9.81e-05	0.00311	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—systemic scleroderma	9.55e-05	0.000911	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—CTGF—systemic scleroderma	9.46e-05	0.003	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Methotrexate—systemic scleroderma	9.23e-05	0.000881	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methotrexate—systemic scleroderma	8.87e-05	0.000847	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—systemic scleroderma	8.8e-05	0.00084	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—systemic scleroderma	8.79e-05	0.000839	CcSEcCtD
Tetrahydrobiopterin—Headache—Methotrexate—systemic scleroderma	8.74e-05	0.000834	CcSEcCtD
Tetrahydrobiopterin—Nausea—Methotrexate—systemic scleroderma	8.29e-05	0.000791	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CCL2—systemic scleroderma	8.14e-05	0.00258	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HSPG2—systemic scleroderma	8.12e-05	0.00258	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CSK—systemic scleroderma	7.84e-05	0.00249	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—IL1B—systemic scleroderma	7.8e-05	0.00248	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SMAD7—systemic scleroderma	7.79e-05	0.00247	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MMP1—systemic scleroderma	7.63e-05	0.00242	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CTGF—systemic scleroderma	7.43e-05	0.00236	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD247—systemic scleroderma	7.37e-05	0.00234	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—HSPG2—systemic scleroderma	6.8e-05	0.00216	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.24e-05	0.00198	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL1B—systemic scleroderma	6.17e-05	0.00196	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RHOB—systemic scleroderma	6.03e-05	0.00191	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MMP9—systemic scleroderma	5.82e-05	0.00185	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HSPG2—systemic scleroderma	5.69e-05	0.0018	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—NOS3—systemic scleroderma	5.63e-05	0.00179	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CSK—systemic scleroderma	5.49e-05	0.00174	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CTGF—systemic scleroderma	5.15e-05	0.00164	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NOS3—systemic scleroderma	4.92e-05	0.00156	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TGFB1—systemic scleroderma	4.79e-05	0.00152	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.73e-05	0.0015	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SMAD7—systemic scleroderma	4.55e-05	0.00144	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFBI—systemic scleroderma	4.16e-05	0.00132	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—NOS3—systemic scleroderma	4.12e-05	0.00131	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TGFB1—systemic scleroderma	3.66e-05	0.00116	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HSPG2—systemic scleroderma	3.32e-05	0.00105	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.26e-05	0.00104	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TGFB1—systemic scleroderma	3.25e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NOS3—systemic scleroderma	3.24e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CSK—systemic scleroderma	3.21e-05	0.00102	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EDN1—systemic scleroderma	3.08e-05	0.000977	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD247—systemic scleroderma	3.02e-05	0.000957	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSPG2—systemic scleroderma	2.78e-05	0.000883	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CTGF—systemic scleroderma	2.11e-05	0.000669	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL2—systemic scleroderma	2.1e-05	0.000668	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TGFB1—systemic scleroderma	1.77e-05	0.000562	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—systemic scleroderma	1.5e-05	0.000478	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFB1—systemic scleroderma	1.24e-05	0.000394	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS3—systemic scleroderma	1.1e-05	0.000348	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NOS3—systemic scleroderma	9.17e-06	0.000291	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFB1—systemic scleroderma	7.24e-06	0.00023	CbGpPWpGaD
